NIVFW NewGenIvf Group Ltd

Price Chart

Executive Summary

NewGenIvf Group entered into a Share Purchase Agreement and Exclusive Agency Agreement with K25.ai (PredicXion Group Limited), an APAC-focused AI prediction market platform. NewGen will acquire an initial 2% equity stake for US$2 million (implied US$100M valuation), payable US$1M in cash/digital assets and 666,667 Class A ordinary shares, with an option to acquire up to an additional 8% under similar terms. The Exclusive Agency Agreement appoints NewGen as K25.ai's exclusive APAC agent in Thailand, Singapore, and Japan, with tiered commissions on gross profit (10% on first US$1M, 7.5% on next US$2M, 5% above) capped at US$5M/year. This represents a strategic pivot into prediction markets for a micro-cap issuer with no disclosed revenue/operating metrics from its legacy IVF business, making the deal highly speculative.

Actionable Insight

Key Facts

• NewGen acquires initial 2% equity in K25.ai for US$2,000,000 (US$1M cash/digital assets + 666,667 Class A shares), implying a US$100M private valuation.
• NewGen has an option to acquire up to an additional 8% within 3 months at US$1M per 1% (50% cash, 50% shares at 110% of Minimum Price), with mandatory exercise on certain financing events.
• Exclusive Agency Agreement in Thailand, Singapore, Japan with tiered commissions: 10% on first US$1M gross profit, 7.5% on US$1-3M, 5% above, capped at US$5M/year.
• Exclusivity requires US$500K annual gross profit per territory; failure for 2 consecutive quarters triggers conversion to non-exclusive.
• K25.ai is an AI-powered watch-to-predict platform not offered in the US, China, Hong Kong, or Macau, with significant regulatory uncertainty across APAC.
• Consideration shares are restricted securities under Regulation S — no registration rights, no trading liquidity for sellers.
• NewGen has conducted six reverse stock splits since February 2025 to maintain Nasdaq listing, with only 240,622 Class A shares outstanding as of Dec 31, 2025.

Financial Impact

NewGen's maximum cash outlay is US$5M (US$1M initial + up to US$4M on full option exercise), with additional share dilution of up to 666,667 shares initially and potentially more on option exercise. Maximum annual commission potential is US$5M, but this requires K25.ai to generate substantial gross profit from NewGen-introduced customers.

Risk Factors

• K25.ai operates in a regulatory gray zone — prediction markets face gambling, securities, and financial services laws in most APAC jurisdictions; the agreement requires local legal opinions before any marketing can commence.
• NewGen has executed 6 reverse stock splits in 13 months and had only ~241K Class A shares outstanding — this suggests severe Nasdaq compliance risk that could impair the value of consideration shares.
• The implied US$100M valuation for K25.ai is based on a US$2M/2% negotiated price between related parties with no independent fairness opinion or third-party valuation.
• The mandatory option exercise clause (Clause 6.4) creates a contingent liability — if NewGen raises capital referencing the K25.ai deal, it must immediately fund US$4M+ to acquire additional shares or face 120% liquidated damages.
• No revenue, user, or financial data for either NewGen's base business or K25.ai's platform is disclosed in the filing, making it impossible to assess the fundamental economics of the deal.

Market Snapshot

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

US Market Status

Related Tickers